Cytomegalovirus DNA, Urogenital Epithelial Cell Scraping (PCR)
The study is aimed at detecting cytomegalovirus (CMV) DNA by PCR in urogenital tract cells.
Used for diagnosing local CMV infection, especially in chronic inflammatory diseases of the urogenital system.
Prescribed for infertility, recurrent pregnancy loss, and preparation for assisted reproductive technologies (ART, IVF).
Allows determination of virus activity at the urogenital tract level and assessment of its possible effect on fertility and reproductive outcomes.
What the test assesses:
– Presence of CMV DNA in urogenital tract epithelial cells.
– Local virus activity.
– Possible role of infection in inflammatory processes and reproductive disorders.
Biomaterial: Urogenital epithelial cell scraping
– Women: submit outside menstruation; do not use vaginal suppositories, creams, or douching for 48 hours.
– Men: do not urinate for 2-3 hours before material collection.
– Avoid sexual contact for 48 hours before the test.
Medications:
– If possible, discontinue antiviral medications 48-72 hours before.
– Do not take antibiotics and antiseptics for 5-7 days (if the clinical situation allows).
– If discontinuation is not possible, be sure to inform the doctor of all medications taken.
Recommended for testing:
– With inflammatory diseases, recurrent pregnancy loss, and pregnancy preparation.
– With chronic urethritis, prostatitis.
– With fertility disorders and decreased sperm quality.
– When preparing for IVF and assessing reproductive risk.
– When urogenital CMV infection is suspected.
– Positive result: CMV DNA detected in epithelial cells, indicating active local infection. Clinical significance assessment is required, and if necessary, antiviral treatment.
– Negative result: CMV DNA not detected; active infection is unlikely.
Important — results should be interpreted together with the clinical picture, serological tests (IgG/IgM), and other reproductive examinations.
